These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 31678273)

  • 1. ZNF382: A transcription inhibitor down-regulated in multiple tumors due to promoter methylation.
    Chen S; Xiao Z; Zhou J; Yang M; Feng S; Huang Q; Zou J; Zeng T; Li Y; Peng L; Zeng Y; Zeng X
    Clin Chim Acta; 2020 Jan; 500():220-225. PubMed ID: 31678273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel 19q13 KRAB zinc-finger tumour suppressor ZNF382 is frequently methylated in oesophageal squamous cell carcinoma and antagonises Wnt/β-catenin signalling.
    Zhang C; Xiang T; Li S; Ye L; Feng Y; Pei L; Li L; Wang X; Sun R; Ren G; Tao Q
    Cell Death Dis; 2018 May; 9(5):573. PubMed ID: 29760376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
    Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas.
    Cheng Y; Geng H; Cheng SH; Liang P; Bai Y; Li J; Srivastava G; Ng MH; Fukagawa T; Wu X; Chan AT; Tao Q
    Cancer Res; 2010 Aug; 70(16):6516-26. PubMed ID: 20682794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a novel Krüpple-like zinc-finger gene, ZNF382, in human heart.
    Luo K; Yuan W; Zhu C; Li Y; Wang Y; Zeng W; Jiao W; Liu M; Wu X
    Biochem Biophys Res Commun; 2002 Dec; 299(4):606-12. PubMed ID: 12459182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 19q13 KRAB zinc-finger protein ZNF471 activates MAPK10/JNK3 signaling but is frequently silenced by promoter CpG methylation in esophageal cancer.
    Sun R; Xiang T; Tang J; Peng W; Luo J; Li L; Qiu Z; Tan Y; Ye L; Zhang M; Ren G; Tao Q
    Theranostics; 2020; 10(5):2243-2259. PubMed ID: 32089740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily.
    Du Y; Carling T; Fang W; Piao Z; Sheu JC; Huang S
    Cancer Res; 2001 Nov; 61(22):8094-9. PubMed ID: 11719434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
    Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
    Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis.
    Liu Z; Zhang J; Gao Y; Pei L; Zhou J; Gu L; Zhang L; Zhu B; Hattori N; Ji J; Yuasa Y; Kim W; Ushijima T; Shi H; Deng D
    Clin Cancer Res; 2014 Sep; 20(17):4598-612. PubMed ID: 25009298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
    Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
    J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
    Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
    Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
    Ortmann CA; Burchert A; Hölzle K; Nitsche A; Wittig B; Neubauer A; Schmidt M
    Nucleic Acids Res; 2005; 33(21):6895-905. PubMed ID: 16396836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells.
    Magdinier F; Billard LM; Wittmann G; Frappart L; Benchaïb M; Lenoir GM; Guérin JF; Dante R
    FASEB J; 2000 Aug; 14(11):1585-94. PubMed ID: 10928993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI; Lee HS; Kim SH; Kim WH
    Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation.
    Lim JH; Kim SP; Gabrielson E; Park YB; Park JW; Kwon TK
    Int J Cancer; 2005 Aug; 116(2):200-6. PubMed ID: 15800911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.